Jardiance — Nutrient Associations & Health Patterns

Also known as: Empagliflozin (Jardiance)

Drug Class: SGLT2 inhibitor (Diabetes medication)

Jardiance is a SGLT2 inhibitor (Diabetes medication) that may affect nutrient status or medication timing in some contexts. WePattern Pattern Health Intelligence maps evidence-qualified nutrient associations, side effects, and interaction context linked to Jardiance.

Reported Nutrient Associations for Jardiance

Peer-reviewed research reports relationships involving the following nutrients. WePattern surfaces them as evidence-qualified associations; they do not establish deficiency, causation, or a fixed timeline for an individual.

Common Side Effects of Jardiance

Key Drug Interactions — Jardiance

Jardiance has 6 documented drug-drug interactions in WePattern's Pattern Health Intelligence database. Key interactions include:

Frequently Asked Questions

What nutrient associations are reported for Jardiance?

Jardiance has reported nutrient associations involving Magnesium, Phosphorus, Vitamin B1, Sodium, Potassium in clinical research. This does not establish that every person will become deficient or that the medication caused an individual result.

Which nutrient relationships are mapped for Jardiance?

WePattern maps reported associations involving: Magnesium, Phosphorus, Vitamin B1, Sodium, Potassium. The strength, mechanism, dose, duration, and clinical relevance vary, so a clinician or pharmacist should interpret them in context.

What are the side effects of Jardiance?

Common side effects associated with Jardiance include: Urinary tract infections; Genital yeast infections; Increased urination; Low blood pressure; Dehydration.

Explore Related Health Intelligence